Incyte (INCY) Cost of Revenue (2010 - 2026)

Incyte has reported Cost of Revenue for 17 years, with the latest figure at $104.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cost of Revenue rose 42.81% year-over-year to $104.5 million; the trailing twelve-month figure through Mar 2026 stood at $403.5 million (up 24.41% YoY), and the FY2025 full-year result was $372.1 million, up 19.25% from the prior year.
• Cost of Revenue for Q1 2026 stood at $104.5 million, down from $121.2 million in the prior quarter.
• The five-year high for Cost of Revenue was $121.2 million in Q4 2025, with the low at $42.6 million in Q1 2022.
• Historically, Cost of Revenue has averaged $73.6 million across 5 years, with a median of $69.8 million in 2023.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 45.84% — and 2025, when it increased 2.78%.
• Incyte's Cost of Revenue stood at $59.2 million in 2022, then grew by 17.9% to $69.8 million in 2023, then gained by 26.86% to $88.5 million in 2024, then jumped by 36.94% to $121.2 million in 2025, then dropped by 13.74% to $104.5 million in 2026.
• The last three Cost of Revenue figures came in at $104.5 million (Q1 2026), $121.2 million (Q4 2025), and $99.0 million (Q3 2025), per Business Quant data.